An elevated pro-inflammatory cytokine profile in multiple chemical sensitivity

Psychoneuroendocrinology

Volumn 40, Issue 1, 2014, Pages 140-150

  Dantoft, T M ^a   Elberling, J ^a   Brix, S ^b   Szecsi, P B ^a   Vesterhauge, S ^c   Skovbjerg, S ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^c Private Hospital ^*  (Denmark)

Author keywords

Case control studies; Cytokines; Immunological regulation; Multiple chemical sensitivity; Sickness behavior

Indexed keywords

ALLERGEN; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR BB; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; ASTHMA; BLOOD LEVEL; COMORBIDITY; CONTROLLED STUDY; CYTOKINE RESPONSE; DANISH; DEPRESSION; DISTRESS SYNDROME; DRUG USE; EMPLOYMENT STATUS; ETHNIC GROUP; FEMALE; HEALTH STATUS; HUMAN; ILLNESS BEHAVIOR; INFLAMMATION; LIMIT OF QUANTITATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORBIDITY; MULTIPLE CHEMICAL SENSITIVITY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIORITY JOURNAL; QUESTIONNAIRE; QUICK ENVIRONMENTAL EXPOSURE AND SENSITIVITY INVENTORY; SELF EVALUATION; SYMPTOM CHECKLIST 92; TH2 CELL; YOUNG ADULT;

CASE-CONTROL STUDIES; CYTOKINES; IMMUNOLOGICAL REGULATION; MULTIPLE CHEMICAL SENSITIVITY; SICKNESS BEHAVIOR;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; COMORBIDITY; CYTOKINES; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; MULTIPLE CHEMICAL SENSITIVITY; YOUNG ADULT;

EID: 84893430698     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2013.11.012     Document Type: Article

References (54)

1. 1999 Consensus on Multiple Chemical Sensitivity Multiple chemical sensitivity: a 1999 consensus. Arch. Environ. Health 1999, 54:147-149.
2. Bazzichi L., Rossi A., Massimetti G., Giannaccini G., Giuliano T., De F.F., Ciapparelli A., Dell'Osso L., Bombardieri S. Cytokine patterns in fibromyalgia and their correlation with clinical manifestations. Clin. Exp. Rheumatol. 2007, 25:225-230.
3. Bell I.R., Baldwin C.M., Schwartz G.E. Sensitization studies in chemically intolerant individuals: implications for individual difference research. Ann. N.Y. Acad. Sci. 2001, 933:38-47.
4. Berg N.D., Linneberg A., Dirksen A., Elberling J. Prevalence of self-reported symptoms and consequences related to inhalation of airborne chemicals in a Danish general population. Int. Arch. Occup. Environ. Health 2008, 81:881-887.
5. Berg N.D., Linneberg A., Thyssen J.P., Dirksen A., Elberling J. Non-allergic cutaneous reactions in airborne chemical sensitivity - a population based study. Int. J. Hyg. Environ. Health 2011, 214:239-245.
6. Biancotto A., Feng X., Langweiler M., Young N.S., McCoy J.P. Effect of anticoagulants on multiplexed measurement of cytokine/chemokines in healthy subjects. Cytokine 2012, 60:438-446.
7. Bornschein S., Hausteiner C., Zilker T., Forstl H. Psychiatric and somatic disorders and multiple chemical sensitivity (MCS) in 264 'environmental patients'. Psychol. Med. 2002, 32:1387-1394.
8. Boyman O., Sprent J. The role of interleukin-2 during homeostasis and activation of the immune system. Nat. Rev. Immunol. 2012, 12:180-190.
9. Broderick G., Fuite J., Kreitz A., Vernon S.D., Klimas N., Fletcher M.A. A formal analysis of cytokine networks in chronic fatigue syndrome. Brain Behav. Immun. 2010, 24:1209-1217.
10. Caccappolo-van V.E., Kelly-McNeil K., Natelson B., Kipen H., Fiedler N. Anxiety sensitivity and depression in multiple chemical sensitivities and asthma. J. Occup. Environ. Med. 2002, 44:890-901.
11. Capuron L., Raison C.L., Musselman D.L., Lawson D.H., Nemeroff C.B., Miller A.H. Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy. Am. J. Psychiatry 2003, 160:1342-1345.
12. Capuron L., Ravaud A., Miller A.H., Dantzer R. Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy. Brain Behav. Immun. 2004, 18:205-213.
13. Caress S.M., Steinemann A.C. A review of a two-phase population study of multiple chemical sensitivities. Environ. Health Perspect. 2003, 111:1490-1497.
14. Chaturvedi A.K., Kemp T.J., Pfeiffer R.M., Biancotto A., Williams M., Munuo S., Purdue M.P., Hsing A.W., Pinto L., McCoy J.P., Hildesheim A. Evaluation of multiplexed cytokine and inflammation marker measurements: a methodologic study. Cancer Epidemiol. Biomarkers Prev. 2011, 20:1902-1911.
15. Christensen U., Schmidt L., Hougaard C.O., Kriegbaum M., Holstein B.E. Socioeconomic position and variations in coping strategies in musculoskeletal pain: a cross-sectional study of 1,287 40- and 50-year-old men and women. J. Rehabil. Med. 2006, 38:316-321.
16. Danahay H., Atherton H., Jones G., Bridges R.J., Poll C.T. Interleukin-13 induces a hypersecretory ion transport phenotype in human bronchial epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 2002, 282:L226-L236.
17. Dantzer R. Cytokine, sickness behavior, and depression. Immunol. Allergy Clin. N. Am. 2009, 29:247-264.
18. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9:46-56.
19. Das-Munshi J., Rubin G.J., Wessely S. Multiple chemical sensitivities: review. Curr. Opin. Otolaryngol. Head Neck Surg. 2007, 15:274-280.
20. De Luca C., Scordo M.G., Cesareo E., Pastore S., Mariani S., Maiani G., Stancato A., Loreti B., Valacchi G., Lubrano C., Raskovic D., De P.L., Genovesi G., Korkina L.G. Biological definition of multiple chemical sensitivity from redox state and cytokine profiling and not from polymorphisms of xenobiotic-metabolizing enzymes. Toxicol. Appl. Pharmacol. 2010.
21. Feghali C.A., Wright T.M. Cytokines in acute and chronic inflammation. Front. Biosci. 1997, 2:d12-d26.
22. Fletcher M.A., Zeng X.R., Barnes Z., Levis S., Klimas N.G. Plasma cytokines in women with chronic fatigue syndrome. J. Transl. Med. 2009, 7:96.
23. Gibson P.R., Elms A.N., Ruding L.A. Perceived treatment efficacy for conventional and alternative therapies reported by persons with multiple chemical sensitivity. Environ. Health Perspect. 2003, 111:1498-1504.
24. Graveling R.A., Pilkington A., George J.P., Butler M.P., Tannahill S.N. A review of multiple chemical sensitivity. Occup. Environ. Med. 1999, 56:73-85.
25. Hart B.L. Biological basis of the behavior of sick animals. Neurosci. Biobehav. Rev. 1988, 12:123-137.
26. Hausteiner C., Bornschein S., Bickel H., Zilker T., Forstl H. Psychiatric morbidity and low self-attentiveness in patients with environmental illness. J. Nerv. Ment. Dis. 2003, 191:50-55.
27. Hausteiner C., Bornschein S., Hansen J., Zilker T., Forstl H. Self-reported chemical sensitivity in Germany: a population-based survey. Int. J. Hyg. Environ. Health 2005, 208:271-278.
28. Johansson A., Bramerson A., Millqvist E., Nordin S., Bende M. Prevalence and risk factors for self-reported odour intolerance: the Skovde population-based study. Int. Arch. Occup. Environ. Health 2005, 78:559-564.
29. Kadetoff D., Lampa J., Westman M., Andersson M., Kosek E. Evidence of central inflammation in fibromyalgia-increased cerebrospinal fluid interleukin-8 levels. J. Neuroimmunol. 2012, 242:33-38.
30. Kipen H., Fiedler N., Maccia C., Yurkow E., Todaro J., Laskin D. Immunologic evaluation of chemically sensitive patients. Toxicol. Ind. Health 1992, 8:125-135.
31. Kreutzer R., Neutra R.R., Lashuay N. Prevalence of people reporting sensitivities to chemicals in a population-based survey. Am. J. Epidemiol. 1999, 150:1-12.
32. Lacour M., Zunder T., Schmidtke K., Vaith P., Scheidt C. Multiple chemical sensitivity syndrome (MCS) - suggestions for an extension of the U.S. MCS-case definition. Int. J. Hyg. Environ. Health 2005, 208:141-151.
33. Locksley R.M. Asthma and allergic inflammation. Cell 2010, 140:777-783.
34. Maes M., Twisk F.N., Kubera M., Ringel K. Evidence for inflammation and activation of cell-mediated immunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): increased interleukin-1, tumor necrosis factor-alpha, PMN-elastase, lysozyme and neopterin. J. Affect. Disord. 2012, 136:933-939.
35. Meggs W.J. Neurogenic inflammation and sensitivity to environmental chemicals. Environ. Health Perspect. 1993, 101:234-238.
36. Miller C.S. Toxicant-induced loss of tolerance - an emerging theory of disease?. Environ. Health Perspect. 1997, 105(Suppl. 2):445-453.
37. Miller C.S., Prihoda T.J. A controlled comparison of symptoms and chemical intolerances reported by Gulf War veterans, implant recipients and persons with multiple chemical sensitivity. Toxicol. Ind. Health 1999, 15:386-397.
38. Miller C.S., Prihoda T.J. The Environmental Exposure and Sensitivity Inventory (EESI): a standardized approach for measuring chemical intolerances for research and clinical applications. Toxicol. Ind. Health 1999, 15:370-385.
39. Minty A., Chalon P., Derocq J.M., Dumont X., Guillemot J.C., Kaghad M., Labit C., Leplatois P., Liauzun P., Miloux B. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993, 362:248-250.
40. Mitchell C.S., Donnay A., Hoover D.R., Margolick J.B. Immunologic parameters of multiple chemical sensitivity. Occup. Med. 2000, 15:647-665.
41. O'Connor M.F., Irwin M.R. Links between behavioral factors and inflammation. Clin. Pharmacol. Ther. 2010, 87:479-482.
42. Olsen L., Mortensen E., Bech P. The SCL-90 and SCL-90R versions validated by item response models in a Danish community sample. Acta Psychiatr. Scand. 2004, 110:161-162.
43. Parham P. The Immune System 2009, Garland Science, Taylor & Francis group, LLC. 3rd ed.
44. Pekkanen J., Sunyer J., Anto J.M., Burney P. European Community Respiratory Health Study Operational definitions of asthma in studies on its aetiology. Eur. Respir. J. 2005, 26:28-35.
45. Punnonen J., Aversa G., Cocks B.G., McKenzie A.N., Menon S., Zurawski G., de Waal M.R., de Vries J.E. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:3730-3734.
46. Skovbjerg S., Berg N.D., Elberling J., Christensen K.B. Evaluation of the Quick Environmental Exposure and Sensitivity Inventory in a Danish population. J Environ Publ Health 2012.
47. Skowera A., Hotopf M., Sawicka E., Varela-Calvino R., Unwin C., Nikolaou V., Hull L., Ismail K., David A.S., Wessely S.C., Peakman M. Cellular immune activation in Gulf War veterans. J. Clin. Immunol. 2004, 24:66-73.
48. Sunyer J., Jarvis D., Pekkanen J., Chinn S., Janson C., Leynaert B., Luczynska C., Garcia-Esteban R., Burney P., Antó J.M., European Community Respiratory Health Survey Study Group Geographic Variations in the Effect of Atopy on Asthma in the European Community Respiratory Health Study 2004, 1033-1039. 114th ed.
49. Vojdani A., Ghoneum M., Brautbar N. Immune alteration associated with exposure to toxic chemicals. Toxicol. Ind. Health 1992, 8:239-254.
50. Whistler T., Fletcher M.A., Lonergan W., Zeng X.R., Lin J.M., Laperriere A., Vernon S.D., Klimas N.G. Impaired immune function in Gulf War Illness. BMC Med. Genomics 2009, 2:12.
51. White A.T., Light A.R., Hughen R.W., Bateman L., Martins T.B., Hill H.R., Light K.C. Severity of symptom flare after moderate exercise is linked to cytokine activity in chronic fatigue syndrome. Psychophysiology 2010, 47:615-624.
52. Winder C. Mechanisms of multiple chemical sensitivity. Toxicol. Lett. 2002, 128:85-97.
53. Yunus M.B. Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness. Semin. Arthritis Rheum. 2008, 37:339-352.
54. Ziem G., McTamney J. Profile of patients with chemical injury and sensitivity. Environ. Health Perspect. 1997, 105(Suppl. 2):417-436.